Ratings for Bicycle Therapeutics (NASDAQ:BCYC) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. The 12-month price targets, analyzed by analysts, offer insights with an average target of $42.25, a high estimate of $55.00, and a low estimate of $28.00. This current average has decreased by 2.87% from the previous average price target of $43.50. Exploring Analyst Ratings: An…